TGFB1 and interstitial lung disease: The results indicate that fibroblasts from ILD patients with mild disease undergoing diagnostic biopsy have higher levels of TGF-β1 and pro-inflammatory pathway signaling than either non-diseased donor tissue or end-stage ILD explant tissue.